Explain this page
Arphra AIPlain-English read on Replimune Group, Inc.’s valuationNo recent stories.
today
- Replimune: Perhaps The FDA Shakeup Will Get A Mulligan For RP134d
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Replimune Group, Inc. – REPL34d
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Replimune Group, Inc. – REPL34d
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL40d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $14.00 (+56.25%)
Candlestick · 1Y
Open in chart workstation →REPL
8.96+28.37%H 10.46L 3.21MA50 6.79MA200 —Avg vol 3.9M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.90% | +6.04% | +71.65% | +21.74% | -6.76% | -7.82% | -8.85% | -62.43% | -74.01% | -40.90% | -40.90% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$110.88K
1 txn
Net flow
−$110.88K
Aftermarket
LiveLast trade
$8.90
10 sh
Bid
$8.77
2 sh
Ask
$8.90
2 sh
Spread
$0.130
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Financial Services+1.26%
- Utilities+0.83%
- Communication Services+0.46%
- Energy+0.45%
- Technology+0.34%
- Consumer Defensive-0.21%
- Industrials-0.32%
- Healthcare-0.39%
- Real Estate-0.67%
- Consumer Cyclical-0.94%
- Basic Materials-1.06%
Top industries (issuer's industry highlighted)
- Biotechnology-0.28%
- Department Stores-6.26%
- Broadcasting-4.30%
- Education & Training Services-3.71%
- Medical - Equipment & Services+3.71%
- Solar-3.63%
- Electronic Gaming & Multimedia+3.56%
- Steel-3.33%
- Real Estate - Development-3.31%
- Trucking-3.16%
- Copper-3.02%
- Coal-2.91%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Replimune: Perhaps The FDA Shakeup Will Get A Mulligan For RP1seekingalpha.com·May 13, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Replimune Group, Inc. – REPLglobenewswire.com·May 12, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Replimune Group, Inc. – REPLglobenewswire.com·May 12, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPLprnewswire.com·May 07, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPLprnewswire.com·Apr 30, 2026
Peers
No peer list available for REPL.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Sarchi Christopher officer: Chief Commercial Officer | Sell | 12,000 | $110.88K | Jun 01, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|